Company Filing History:
Years Active: 1990
Title: The Innovations of James W. Dorman: A Pioneer in Immunomodulatory Research
Introduction: James W. Dorman, hailing from West Chester, Pennsylvania, is a notable inventor recognized for his significant contributions to the field of immunomodulation. His pivotal work has led to the development of a unique pharmaceutical composition aimed at enhancing the immune response, which showcases the impact of his research on medical science.
Latest Patents: Dorman holds one patent titled "Immunomodulatory azaspiranes." This patent describes a pharmaceutical composition that includes a pharmaceutically acceptable carrier or diluent alongside an effective amount of an azaspirane derivative. The invention reveals methods of treating animals in need of immunomodulation, emphasizing the administration of the azaspirane derivative, along with detailing specific azaspirane derivatives used in the formulation.
Career Highlights: Throughout his career, James W. Dorman has made substantial advancements in pharmaceutical research while working at SmithKline Beecham Corporation. His extensive research and dedication to developing innovative treatments have established him as a key figure in the biomedical field. His efforts have contributed significantly to the understanding of immunomodulatory treatments.
Collaborations: Dorman has collaborated with esteemed colleagues such as Alison Mary Badger and Elaine N. Cheeseman. Their joint efforts have fostered an environment of innovation and discovery, leading to advancements in their respective fields and ensuring that significant research is brought to fruition.
Conclusion: James W. Dorman's work exemplifies the vital role of inventors in advancing scientific knowledge and improving healthcare outcomes. His patent on immunomodulatory azaspiranes contributes to the ongoing evolution of pharmaceutical compositions and highlights the importance of collaboration in research. As he continues his journey in the field, Dorman's legacy will inspire future innovations that benefit both humans and animals alike.